Literature DB >> 12219007

Transfer of "infectious" cardiac allograft tolerance induced by donor-specific transfusion.

Masaaki Kataoka1, Yoshiaki Shimizu, Julie A Margenthaler, Keith Landeros, Naoki Otomo, M Wayne Flye.   

Abstract

BACKGROUND: "Infectious tolerance" has been defined as the tolerance induced in a new recipient by the adoptive transfer of cells from a recipient accepting an allograft after anti-CD4 and anti-CD8 monoclonal antibody treatment. A clear understanding of the mechanisms responsible for graft acceptance after donor-specific blood transfusion (DST) has remained elusive. We examined the development and "infectious" nature of immunologic changes resulting in indefinite survival of LEW to DA rat cardiac allografts after DST alone without the need for antibody.
METHODS: One hundred x 10(6) LEW splenocytes (SC) as DST were injected intravenously into DA recipients 7 days before LEW cardiac transplantation. Subsequently, 100 x 10(6) SC harvested from a DA recipient 30, 60, or 100 days after graft acceptance were adoptively transferred into lightly gamma-irradiated (450 rad) naïve DA recipients 24 hours before a second LEW cardiac allograft. Subsequent graft function was determined.
RESULTS: Adoptive transfer of SC from the DST-treated DA rats 30 days after LEW heart transplant acceptance into naïve gamma-irradiated DA rats failed to transfer tolerance to LEW cardiac allografts. However, SC from DA rats bearing LEW hearts for more than 60 days induced indefinite tolerance to all LEW hearts. This infectious tolerance could be adoptively transferred again to a second DA recipient.
CONCLUSIONS: DST-generated regulatory cells can downregulate naïve lymphocytes to promote allograft acceptance. This tolerance can be expanded and serially transferred to a subsequent naïve cardiac recipient.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12219007     DOI: 10.1067/msy.2002.125303

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  3 in total

1.  Infectious tolerance to ADP/ATP carrier peptides induced by anti-L3T4 monoclonal antibody in dilated cardiomyopathy mice.

Authors:  Yu-Hua Liao; Jing Yuan; Zhao-Hui Wang; Xiang Cheng; Jing-Hui Zhang; Yuan Tian; Ji-Hua Dong; He-Ping Guo; Min Wang
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

2.  Host-based Th2 cell therapy for prolongation of cardiac allograft viability.

Authors:  Shoba Amarnath; Hao Chen; Jason E Foley; Carliann M Costanzo; Joel D Sennesh; Michael A Solomon; Daniel H Fowler
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

3.  Recipient natural killer cells alter the course of rejection of allogeneic heart grafts in rats.

Authors:  Oliver Beetz; Joline Kolb; Benjamin Buck; Britta Trautewig; Kai Timrott; Florian W R Vondran; Ingrid Meder; Corinna Löbbert; Joachim Hundrieser; Jürgen Klempnauer; Hüseyin Bektaş; Thorsten Lieke
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.